Company · CIK 0001831828 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Vera Therapeutics, Inc. · VERA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 17, 4:28 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | $37.00 | $684,500 | 235,244 | −7.29% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:28 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | $2.90 | $53,591 | 253,744 | — | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 14, 4:28 pm EDT | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | 5,000 | $3.94 | $19,698 | 80,754 | — | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:15 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | $35.12 | $649,642 | 235,244 | −7.29% | 10b5-1 |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:15 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | $2.90 | $53,591 | 253,744 | — | 10b5-1 |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:14 pm EDT | Nancy Lee BomanChief Regulatory Officer | 44,987 | — | — | 44,987 | — | |
| Jul 7, 2026 SForm 4/A → | Aug 12, 6:42 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 46,250 | $42.30 | $1,956,187 | 235,244 | −16.4% | 10b5-1 |
| Jul 7, 2026 MForm 4/A → | Aug 12, 6:42 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 46,250 | $2.90 | $133,977 | 281,494 | — | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 4:45 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 46,250 | $42.30 | $1,956,187 | 151,994 | −23.3% | 10b5-1 amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:28 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | — | — | 488,801 | — | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 14, 4:28 pm EDT | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | 5,000 | — | — | 33,589 | — | |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:15 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 18,500 | — | — | 507,301 | — | 10b5-1 |
| Aug 3, 2026 AForm 4 → | Aug 5, 4:14 pm EDT | Nancy Lee BomanChief Regulatory Officer | 63,011 | — | — | 63,011 | — | |
| Jul 7, 2026 MForm 4/A → | Aug 12, 6:42 pm EDT | Marshall FordycePRESIDENT AND CEO, Director | 46,250 | — | — | 525,801 | — | 10b5-1 |